1999
DOI: 10.1086/314717
|View full text |Cite
|
Sign up to set email alerts
|

Dose‐Related Inflammatory Effects of Intravenous Endotoxin in Humans: Evaluation of a New Clinical Lot ofEscherichia coliO:113 Endotoxin

Abstract: The administration of reference endotoxin (Escherichia coli O:113, Lot EC-5) to humans has been an important means to study inflammation in vivo; however, the supply of Lot EC-5 is depleted. A new lot of reference endotoxin (Clinical Center reference endotoxin [CCRE]), derived from the original bulk material extracted from E. coli O:113, was processed. The effects of 0-, 1-, 2-, and 4-ng/kg doses of intravenous CCRE and EC-5 were studied in 20 male subjects. CCRE resulted in dose-related increases in symptoms,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

5
114
1

Year Published

2003
2003
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 134 publications
(121 citation statements)
references
References 13 publications
5
114
1
Order By: Relevance
“…It is not apparent why different results are obtained. However, the current study used different lots of E. coli, which might have implication [16]. In septic patients, plasma cGMP increases [31] and, in volunteers, NO inhalation increases plasma cGMP in a dose-dependent manner [32].…”
Section: Discussionmentioning
confidence: 94%
See 1 more Smart Citation
“…It is not apparent why different results are obtained. However, the current study used different lots of E. coli, which might have implication [16]. In septic patients, plasma cGMP increases [31] and, in volunteers, NO inhalation increases plasma cGMP in a dose-dependent manner [32].…”
Section: Discussionmentioning
confidence: 94%
“…Nitrite/nitrate and cGMP in plasma were also analysed. Healthy volunteers were exposed to 4 ng?kg -1 Escherichia coli endotoxin, a dose that induces a prominent inflammatory response without being hazardous to the subject [16].…”
mentioning
confidence: 99%
“…The study was approved by the institutional review board of the Clinical Research Center, New Orleans, and reviewed by the institutional review board of the National Institute of Allergy and Infectious Diseases ( 28 ). Twelve healthy male volunteers aged 22-49 years underwent a complete history and physical examination prior to entering the study.…”
Section: Human Studiesmentioning
confidence: 99%
“…The volunteers were premedicated with one double-strength trimethoprim/sulfamethoxazole tablet 12 h and 1 h before bronchoscopy. Subjects with a history of sulfa allergy were given two doses of oral amoxicillin (500 mg), separated by 8 h. At the time of the first bronchoscopy, 10 ml of saline was instilled into a lung subsegment (either the right middle lobe or lingula, followed by instillation of the test dose of reference LPS (O:113; National Institutes of Health, Bethesda, MD) (19,20) 4 ng/kg in 10 ml of saline into the contralateral lung. The subjects were randomized to left or right lungs for LPS or saline instillation.…”
Section: Model Of Lps-induced Pulmonary Inflammationmentioning
confidence: 99%